BPH Global Registry

Part of paid clinical trials in Los Angeles, California.

Sponsor
Société Internationale d'Urologie
Study ID
NCT05543200
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
MALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Benign prostatic hyperplasia (BPH) is one of the most common performed surgical procedures in urology. Over the past few decades there have been an increasing development of newer surgical treatment options. Additionally, the outcome parameters for BPH treatments have been standardized. While data are available for the initial pivotal studies, post-market release data are lacking. Under the umbrella of uCARE, we have started a prospective, ongoing international registry for recording demographics and outcomes for patients undergoing surgical treatments for BPH.

Key Dates

Start date
Mar 13, 2023
Status verified
May 2025
Primary completion
Dec 31, 2026
Completion
Mar 31, 2027

Study Design

Enrollment
7,500 participants (estimated)

Arms

  • Arm: All Participants
    All men who have a primary diagnosis of BPH with LUTS that are prescribed BPH medications or a surgical intervention.

Primary Outcome Measure

International Prostate Symptom Score (IPSS) [ Time Frame: 36 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Keck Medicine of USCLos AngelesCalifornia90089
Mihir Desai, MD
Mihir Desai, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Los Angeles, CA

By research site
Keck Medicine of USC· Los Angeles, CA

Related Studies